Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.22T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.40% | 21.33 | 16.01 | 0.22 | -1.93% | 4.98% | +53.36% | +11.37% | 0.89 | |||||
351 | MRSN | Mersana Therapeutics Inc | $29.08 | $145M | -15.54% | N/A | N/A | N/A | -51.16% | N/A | N/A | N/A | N/A | -38.99% | N/A |
352 | MIST | Milestone Pharmaceuticals Inc | $1.31 | $144M | -14.90% | N/A | N/A | N/A | -35.82% | N/A | 75 | +383.21% | $6.33 | -26.36% | 1.51 |
353 | CRBP | Corbus Pharmaceuticals Holdings Inc | $8.05 | $143M | -33.12% | N/A | N/A | N/A | -51.58% | N/A | 77 | +353.42% | $37 | -33.02% | 1.22 |
354 | RANI | Rani Therapeutics Holdings Inc Class A | $0.77 | $141M | N/A | N/A | N/A | N/A | -12.14% | N/A | 81 | +880.14% | $7.50 | 0.00% | 2.22 |
355 | MOLN | Molecular Partners AG | $3.90 | $140M | -2.74% | N/A | 1.70 | N/A | -48.80% | N/A | 70 | +181.54% | $11 | -27.34% | 0.63 |
356 | ADCT | Adc Therapeutics SA | $1.10 | $139M | N/A | N/A | N/A | N/A | -82.29% | N/A | 79 | +356.62% | $5 | -45.73% | 1.48 |
357 | PROK | ProKidney Corp - Class A | $1.75 | $138M | N/A | N/A | N/A | N/A | N/A | N/A | 57 | +257.14% | $6.25 | 0.00% | 2.41 |
358 | TCRX | Tscan Therapeutics Inc | $0.90 | $138M | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +566.74% | $6 | 0.00% | 1.29 |
359 | VXRT | Vaxart Inc | $0.57 | $137M | N/A | 3.81 | 42.73 | N/A | 10.63% | N/A | N/A | N/A | N/A | -40.77% | N/A |
360 | HURA | TuHURA Biosciences Inc | $2.22 | $132M | N/A | N/A | N/A | N/A | -20.71% | N/A | 87 | +262.16% | $8.04 | -76.95% | N/A |
361 | MENS | Jyong Biotech Ltd | $1.60 | $131M | N/A | N/A | N/A | N/A | -2.33% | N/A | N/A | N/A | N/A | 0.00% | 2.34 |
362 | CNTB | Connect Biopharma Holdings Ltd | $2.08 | $130M | N/A | N/A | 0.77 | N/A | -44.16% | N/A | 75 | +239.90% | $7.07 | 0.00% | 0.12 |
363 | GNLX | Genelux Corp | $2.85 | $128M | N/A | N/A | N/A | N/A | -21.74% | N/A | 79 | +514.04% | $18 | 0.00% | 1.47 |
364 | CGTX | Cognition Therapeutics Inc | $1.42 | $127M | N/A | N/A | N/A | N/A | -15.96% | N/A | 75 | +146.48% | $3.50 | 0.00% | 1.86 |
365 | NBP | NovaBridge Biosciences. | $1.57 | $127M | N/A | N/A | 2.68 | N/A | N/A | N/A | 75 | +409.55% | $8 | -53.65% | 0.91 |
366 | NRXP | NRX Pharmaceuticals Inc | $3.98 | $126M | N/A | N/A | 34.25 | N/A | -11.86% | N/A | 75 | +955.28% | $42 | -51.52% | 1.07 |
367 | COYA | Coya Therapeutics Inc | $5.03 | $118M | N/A | N/A | N/A | N/A | -11.97% | N/A | 75 | +202.39% | $15 | 0.00% | 1.09 |
368 | GUTS | Fractyl Health Inc | $0.85 | $116M | N/A | N/A | N/A | N/A | -75.66% | N/A | 70 | +516.47% | $5.24 | 0.00% | 1.10 |
369 | SAVA | Cassava Sciences Inc. | $2.38 | $115M | +43.62% | N/A | 151.52 | N/A | -26.42% | N/A | N/A | +236.13% | $8 | 0.00% | N/A |
370 | AGEN | Agenus Inc | $2.96 | $114M | N/A | 1.78 | 1.44 | N/A | -76.76% | N/A | 75 | +423.65% | $16 | -50.85% | 1.39 |
371 | RPTX | Repare Therapeutics Inc | $2.65 | $114M | N/A | N/A | N/A | N/A | -61.58% | N/A | N/A | N/A | N/A | -39.98% | N/A |
372 | NTHI | NeOnc Technologies Holdings Inc | $4.81 | $113M | N/A | N/A | N/A | N/A | -19.22% | N/A | 75 | +232.64% | $16 | 0.00% | N/A |
373 | ALDX | Aldeyra Therapeutics Inc | $1.83 | $110M | -15.26% | N/A | N/A | N/A | -23.54% | N/A | 75 | +315.30% | $7.60 | -31.26% | 1.31 |
374 | ENGN | enGene Holdings Inc | $1.74 | $107M | N/A | N/A | N/A | N/A | -96.83% | N/A | 59 | +88.85% | $3.29 | 0.00% | 0.89 |
375 | PYXS | Pyxis Oncology Inc | $1.90 | $105M | N/A | N/A | N/A | N/A | -63.83% | N/A | 75 | +268.42% | $7 | 0.00% | 1.43 |
376 | HLVX | HilleVax Inc | $2.09 | $105M | N/A | N/A | N/A | N/A | -57.13% | N/A | N/A | N/A | N/A | 0.00% | N/A |
377 | SEER | Seer Inc - Class A | $1.72 | $103M | N/A | N/A | N/A | N/A | -48.24% | N/A | 75 | +132.56% | $4 | -44.73% | 0.57 |
378 | ADVM | Adverum Biotechnologies Inc | $4.36 | $102M | -8.32% | N/A | N/A | N/A | N/A | N/A | N/A | +11.81% | $4.88 | -34.69% | 1.08 |
379 | VRCA | Verrica Pharmaceuticals Inc | $5.83 | $100M | N/A | N/A | N/A | N/A | -14.09% | N/A | 70 | +166.55% | $16 | -44.99% | 0.58 |
380 | KZIA | Kazia Therapeutics Ltd | $14.25 | $98M | N/A | N/A | 12.82 | 1.01 | N/A | N/A | 91 | +81.61% | $26 | -51.20% | 1.67 |
381 | VANI | Vivani Medical Inc | $1.15 | $97M | N/A | N/A | N/A | N/A | -27.25% | N/A | 83 | +320.26% | $4.83 | -43.23% | 0.95 |
382 | PEPG | PepGen Inc | $1.70 | $97M | N/A | N/A | N/A | N/A | -79.59% | N/A | 64 | +496.47% | $10 | 0.00% | 0.75 |
383 | BDTX | Black Diamond Therapeutics Inc | $1.67 | $96M | -20.40% | N/A | 8.33 | N/A | -35.56% | N/A | 77 | +490.42% | $9.86 | -33.19% | 1.73 |
384 | KLRS | Kalaris Therapeutics Inc | $4.55 | $96M | -39.47% | N/A | N/A | N/A | -44.65% | N/A | 78 | +312.09% | $19 | -60.22% | 0.84 |
385 | CSBR | Champions Oncology Inc | $6.82 | $95M | +4.69% | N/A | 22.88 | N/A | 4.03% | N/A | N/A | +75.95% | $12 | -4.20% | 0.69 |
386 | OTLK | Outlook Therapeutics Inc | $1.65 | $93M | -28.21% | N/A | 2.85 | N/A | -50.53% | N/A | 62 | +233.33% | $5.50 | -49.53% | 0.98 |
387 | ONCY | Oncolytics Biotech Inc | $0.93 | $93M | N/A | N/A | 45.45 | N/A | -21.65% | N/A | 83 | +435.63% | $4.99 | -20.42% | 0.87 |
388 | PTHS | Channel Therapeutics Corporation | $27.01 | $92M | N/A | N/A | N/A | N/A | -38.29% | N/A | 78 | +113.66% | $58 | 0.00% | 1.12 |
389 | FBIO | Fortress Biotech Inc | $3.07 | $92M | N/A | 0.71 | 1.23 | N/A | N/A | N/A | 75 | +258.31% | $11 | -43.32% | 0.82 |
390 | PMN | ProMIS Neurosciences Inc | $10.38 | $92M | N/A | N/A | N/A | N/A | -38.89% | N/A | 85 | +235.93% | $35 | +17.95% | 0.45 |
391 | ANIX | Anixa Biosciences Inc | $2.69 | $91M | -3.53% | N/A | N/A | N/A | -7.80% | N/A | 83 | +271.75% | $10 | -7.40% | 1.35 |
392 | ICCC | Immucell Corp | $9.39 | $88M | -26.43% | N/A | N/A | N/A | 3.86% | N/A | N/A | +49.17% | $14 | -0.70% | 0.29 |
393 | ATHE | Alterity Therapeutics Ltd | $5.14 | $87M | N/A | N/A | N/A | N/A | -23.66% | N/A | 100 | +133.46% | $12 | -17.68% | 1.01 |
394 | CUE | Cue Biopharma Inc | $26.73 | $87M | -30.28% | N/A | N/A | N/A | -28.28% | N/A | 75 | +330.23% | $115 | -41.10% | 1.55 |
395 | ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $0.05 | $87M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -57.48% | N/A |
396 | BMEA | Biomea Fusion Inc | $1.20 | $87M | N/A | N/A | N/A | N/A | -64.98% | N/A | 71 | +469.17% | $6.83 | -43.03% | 1.55 |
397 | LPTX | Leap Therapeutics Inc | $2.05 | $85M | N/A | N/A | N/A | N/A | -70.88% | N/A | 0 | +46.34% | $3 | -33.70% | 1.36 |
398 | RLYB | Rallybio Corp | $15.92 | $84M | N/A | N/A | N/A | N/A | -32.71% | N/A | 50 | -49.75% | $8 | 0.00% | 0.97 |
399 | CBUS | Cibus Global Ltd. Class A | $1.29 | $84M | +13.78% | N/A | N/A | N/A | -60.22% | N/A | 66 | +1037.21% | $15 | 0.00% | 2.04 |
400 | AARD | Aardvark Therapeutics Inc | $3.82 | $83M | N/A | N/A | N/A | N/A | -74.09% | N/A | 56 | +304.19% | $15 | 0.00% | 1.62 |